Preoperative Administration of Olaparib With or Without Cisplatin in Patients Who Are Candidates for Surgery of Carcinoma of Head and Neck

Condition:   Squamous Cell Carcinoma of the Head and Neck
Interventions:   Drug: Olaparib;   Drug: Cisplatin;   Drug: Olaparib
Sponsors:   Hellenic Cooperative Oncology Group;   AstraZeneca;   Pfizer
Not yet recruiting - verified August 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/2bv5zU9
via IFTTT